Search - tctmd.com

Displaying 241 - 260 of 426

Sort: Relevancy | Date

Presentation TCT 2015

Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention

Presenter: Eric R. Bates, Neal S. Kleiman, Ori Ben-Yehuda

October 15, 2015

Presentation TCT 2015

Should You Bridge in Stented Patients Needing Surgery?

Presenter: Eric R. Bates, Neal S. Kleiman, David F. Kong

October 15, 2015

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

News Daily News

ADAPT-DES Substudy: Practice Changes May Decrease Already Low Stent Thrombosis Rates Even Further

Yael L. Maxwell

October 09, 2015

News Industry News

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

September 21, 2015

News Daily News

RECLOSE-3: Shifting Clopidogrel Nonresponders to Prasugrel Lowers Mortality After PCI

Yael L. Maxwell

September 18, 2015

News Conference News ESC 2015

High-Sensitivity Troponin Assay Use Does Not Appear to Increase Diagnostic Procedures

L.A. McKeown

September 02, 2015

News Conference News ESC 2015

DAPT Analysis Eases Concerns Over Slightly Higher Death Rate Seen With Extended Thienopyridine Use

Caitlin E. Cox

September 01, 2015

News Conference News ESC 2015

Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI

Yael L. Maxwell

August 31, 2015

News Daily News

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

August 04, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Daily News

Single-Center Study Adds Further Data to Debate Over PFO Closure

July 06, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Todd Neale

June 29, 2015

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

News Daily News

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

Leah Lawrence

April 29, 2015

News Daily News

活化凝血时间可能预测单纯使用肝素的 PCI 的缺血事件

L.A. McKeown

April 28, 2015

News Daily News

El Tiempo de Coagulación Activado podría Predecir los Episodios Isquémicos en Pacientes PCI a Tratamiento Solo con Heparina

L.A. McKeown

April 28, 2015

News Daily News

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

L.A. McKeown

April 28, 2015

Advertisement

Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention

Should You Bridge in Stented Patients Needing Surgery?

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

ADAPT-DES Substudy: Practice Changes May Decrease Already Low Stent Thrombosis Rates Even Further

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

RECLOSE-3: Shifting Clopidogrel Nonresponders to Prasugrel Lowers Mortality After PCI

High-Sensitivity Troponin Assay Use Does Not Appear to Increase Diagnostic Procedures

DAPT Analysis Eases Concerns Over Slightly Higher Death Rate Seen With Extended Thienopyridine Use

Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Single-Center Study Adds Further Data to Debate Over PFO Closure

Method Chosen to Estimate Pre-PCI Kidney Function Matters

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

活化凝血时间可能预测单纯使用肝素的 PCI 的缺血事件

El Tiempo de Coagulación Activado podría Predecir los Episodios Isquémicos en Pacientes PCI a Tratamiento Solo con Heparina

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content